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Cardiovascular disease, especially occlusive ather-
osclerosis involving the coronary, cerebrovascular,
and peripheral arterial systems, continues to be the
leading cause of death in western countries.1
Angiography and other techniques can be used for
ready detection of severe and hemodynamically sig-
nificant arterial stenosis or occlusion, and such
lesions can be managed with bypass operations and
interventional therapies such as transluminal angio-
plasty. In contrast, noncritical stenosis has largely
been ignored. However, rupture of a nonocclusive
plaque surface with rapid plaque enlargement is
probably the most important mechanism responsible
for acute cardiovascular syndromes.2 Composition
rather than plaque size is the most important deter-
minant of plaque rupture. Plaques rich in extracellu-
lar lipids covered by a thin fibrous cap are most vul-
nerable.3-6 Although treatments are available to pro-
mote regression of these plaques,7-9 no methods are
available to help identify such lesions in situ and
determine their composition. Most pathologic infor-
mation comes from studies of vascular segments
excised after treatment failure, autopsy samples, and
atherectomy specimens.
An in situ method for determining composition
of arterial lesions could provide valuable information
for guiding treatment. A variety of treatment tech-
niques are available, such as angioplasty, bypass
grafting, atherectomy, laser recanalization, and drug
therapy. In the case of balloon angioplasty, for exam-
ple, in which there is a high degree of restenosis
within 6 months (30% to 40%),10 chemical compo-
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sition may be an important factor in determining
which lesions will restenose. A method for in situ
histochemical analysis could be valuable in selecting
the most appropriate intervention for managing a
particular arterial lesion.
Noninvasive methods such as external ultra-
sonography,11 spiral computed tomography12 and
magnetic resonance imaging can provide informa-
tion regarding vessel wall thickness and plaque char-
acteristics.13,14 Hypoechogenicity and severe plaque
calcification are easily detected with ultrasonogra-
phy, but identification of smaller amounts of lipids
or calcium is still not possible. Angioscopy can pro-
vide more detailed information about the intralumi-
nal surface of the plaque characteristics but little
information regarding chemical composition.15-17
Intravascular ultrasonography is the most accurate
modality currently available to assess arterial struc-
ture in vivo. In an in vitro study of pressure-perfused
human coronary arteries, small deposits of calcium
and lipids (~0.25 mm in dimension) were visual-
ized.18 For lipid deposits, ultrasonography has a sen-
sitivity of 46% and a specificity of 97%; for calcific
deposits these values are 77% and 100%.
Optical spectroscopy provides potential means
for determining plaque composition in vivo. By
means of illumination of an arterial segment with a
weak beam of incident light and analysis of the
return light, information about the tissue can be
obtained.19,20 The re-emitted light may contain
spectroscopic information of several types. First,
there is a reflected component, in which the emitted
frequency equals the incident frequency. Emission
also may occur at other frequencies.21 In one such
process, fluorescence, incident photons raise an
absorbing molecule to an excited state, and light is
re-emitted at a frequency characteristic of the elec-
tronic structure of the molecule. Spectroscopic tech-
niques based on fluorescence have been used suc-
cessfully to classify normal and diseased arterial tis-
sue.22 However, these techniques are not capable of
providing quantitative information about arterial
composition, in part because the fluorescence spec-
tra of many arterial compounds are similar.23
The Raman effect is another spectroscopic
process that generates frequency-shifted light. In this
case the incident light causes the molecule to change
from one vibrational energy level to another, and the
re-emitted light is shifted in frequency by the molec-
ular vibrational frequency. Raman frequency shifts
(commonly measured in units of inverse wavelength
or wave numbers [cm–1]) thus provide direct infor-
mation about the type and distribution of molecules
in the tissue. Unlike fluorescence, the incident light
need not be absorbed by the interacting molecules.
Raman signals are exceedingly weak. However, with
recent technologic advances,20 rapid and accurate
detection of these small signals is now possible.
Because the Raman effect provides molecule-
based information, Raman spectra can provide
detailed information about arterial chemical compo-
sition.19 However, because of the complexity and
subtle features of the spectra, extraction of quantita-
tive information requires detailed modeling. We
have developed a method for using Raman spec-
troscopy to quantify the content of lipids and calci-
um salts in coronary artery tissue.24 We also have
developed a diagnostic scheme in which the relative
concentrations of total cholesterol and calcium salts
thus obtained are used to classify the samples into
nondiseased and diseased tissue types.25 These
results are of particular interest because optical fibers
can be used to deliver the incident light and collect
the re-emitted light, and Raman spectroscopy can
thus be used to obtain diagnostic information clini-
cally through catheters.19,20
It is of interest to extend the applicability of
Raman spectroscopy to peripheral arteries. Important
clinical diagnostic applications can be envisioned.
Raman studies of peripheral arteries provide impor-
tant opportunities for evaluating the accuracy of
Raman measurements in an in vivo setting, in which
the same arterial tissue can be examined in situ and
then surgically removed for histologic examination.
Such direct comparison is not usually possible with
coronary arteries.
The objective of this study was to demonstrate
that the Raman method developed for analysis of
coronary arteries can be applied to carotid and
femoral arteries. In vitro samples were studied. We
wanted to show that the previously developed spec-
tral model can be accurately fitted to the Raman
spectra from these medium-sized vessels and that the
chemical composition thus obtained is in agreement
with histologic findings.
METHODS
This study was a collaboration among researchers
from MetroWest Medical Center, the New England
Deaconess Hospital, and the Massachusetts Institute
of Technology. The protocol was approved by the
appropriate institutional review boards for human
studies, and informed consent was obtained from all
patients enrolled.
Tissue supply. Three arterial specimens were
collected during carotid endarterectomy and one
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during femoropopliteal bypass grafting. Each speci-
men was immediately frozen in liquid nitrogen and
stored at –80° C until use (3 to 150 days of storage).
Raman spectroscopy instrumentation. After
passive thawing in phosphate buffered saline solution
(pH 7.4), specimens were cut into segments ranging
in area from 4 to 25 mm2. The study used 167 sam-
ples in all. Each sample was evaluated under 10 ·
magnification and graded qualitatively as normal,
fibrotic, or calcified tissue. The samples were irradi-
ated with a 100 m m diameter spot of 830 nm near-
infrared light from an argon ion–pumped titanium-
sapphire laser system (Fig. 1).20 The power incident
on the tissue was 350 mW. The re-emitted light was
filtered optically to remove the reflected component
and imaged onto the slit of a change-coupled device
spectrometer system. Overall spectral resolution was
8 cm–1. Each spectrum was collected in 60 seconds.
After spectral measurement, the irradiated areas on
the artery were marked with colored dots of colloidal
ink (0.5 to 1.0 mm diameter), and the samples were
fixed in 10% buffered formalin solution.
Raman spectra processing. The raw spectra con-
tain a broad background, slowly varying in wave-
length, that is much larger than the sharply-peaked
Raman signals. To remove this background, spectra
were fit to a fourth-order polynomial by means of
least-squares minimization. The polynomial was then
subtracted to derive a processed Raman spectrum. Our
Raman spectral model24 was applied to these spectra
by means of the procedure previously described.24 The
model fit a linear combination of Raman spectral com-
ponents—free cholesterol (FC), cholesterol ester (CE),
total triglycerides, and phosopholipids (TG&PL), cal-
cium salts (CS), and delipidized artery (DA)—to the
processed Raman spectrum. From that were comput-
ed the relative percentage weight of each. The per-
centage weights of total cholesterol and calcium salts
were then computed. The amount of total cholesterol
in the noncalcified regions was computed as TC = (FC
+ CE) ÷ (FC + CE + TG&PL + DA).
Histochemical examination. Heavily calcified
tissues were decalcified to the point of being able to
be cut on a microtome. All tissues were processed
routinely for paraffin embedding, and five step sec-
tions were prepared from tissue at the center of each
ink mark. Sections were stained with hematoxylin
and eosin and examined by a blinded experienced
cardiovascular pathologist (T. A.). The pathologist
ranked each sample by its cholesterol content and
then by its calcium mineral content. Tissue within a
1 mm radius of the ink markings was evaluated for
presence of cholesterol, indicated by the presence of
foam cells and cholesterol crystals, and of calcium
mineral deposits. The areas occupied by each of these
constituents were ranked on a scale of 0 to 3. Level 0
corresponded to an absence of the constituents. In
level 1 less than 10% of the tissue sample was occu-
pied; in level 2 from 10% to 50% and in level 3 more
than 50% was occupied. A similar evaluation and
ranking was carried out for calcium salt content.
Comparison of spectroscopy and histology
examination. The samples were grouped according
to cholesterol content, as determined at pathologic
examination, and histograms of the content of total
cholesterol within each group were constructed.
The same procedure was done for calcium salt con-
tent in each group. The mean value and standard
Fig. 1. Block diagram of Raman spectroscopy system. CCD, change-coupled device. 
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deviation of both total cholesterol and calcium salt
within a group were calculated. These data were
plotted as a function of cholesterol content and cal-
cium mineral content, respectively.
To compare the results of Raman analysis with
those of pathologic examination, for lipids we
grouped levels 1, 2, and 3 into a diseased category
and classified level 0 as normal, that is, nonathero-
sclerotic with regard to total cholesterol content.
The amount of total cholesterol, determined with
spectroscopy, was used as a parameter to differenti-
ate these two tissue categories. Samples with total
cholesterol content above a given threshold level
were called diseased. The total cholesterol threshold
was varied, and the sensitivity and specificity of the
diagnostic test were plotted on a relative operating
characteristics (ROC) curve.26,27 The ROC curve
describes the tradeoff between sensitivity and speci-
ficity as a decision threshold is varied.
For calcium salts we also grouped levels 1, 2, and
3 into a diseased category and classified level 0 as
normal, that is, nonatherosclerotic with regard to
calcium mineral content. Calcium salts content mea-
sured with spectroscopy was used as a parameter to
separate these two categories. Diagnostic potential
was similarly evaluated with ROC curves.
RESULTS
Correlation of Raman spectroscopic and histo-
logic findings for various arterial lesions is shown in
Fig. 2. Low-power photomicrograph (original magnification, · 20) of cross sections from
three typical arterial lesions and their corresponding spectra. Top, Fibrofatty plaque with lipid
core in the upper part of the lesion. Corresponding cholesterol ring–related spectra diminish
from top to bottom. Center, Plaque with heavy calcification in the upper portion of the lesion
and corresponding strong phosphate peak. Bottom, Fibrous plaque with scattered microcalci-
fications.
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Fig. 2. Three representative spectra of peripheral
artery exhibiting different manifestations of athero-
sclerotic disease are shown in Fig. 3. Fits of the coro-
nary artery model to the spectra, along with the
residuals obtained by subtracting the model spec-
trum from the arterial spectrum, also are shown.
The nondiseased spectrum was dominated by pro-
tein features such as the amide I and III modes at
1650 and 1250 cm–1, respectively, and methelyne
bending modes at 1450 cm–1. The 930 and 860
cm–1 bands are from the vibrations of proline and
hydroxyproline, which are major components of col-
lagen. In noncalcified plaques, spectral features of
cholesterol and cholesterol esters constitute the
main part of the Raman spectrum. The sharp spec-
tral feature at 1667 cm–1 is from the vibration
stretching of carbon-carbon double bonds present in
the hydrocarbon chains of cholesterol and fatty
acids, and the methelyne bending modes (1440
cm–1) in lipids are slightly lower than those of pro-
Fig. 3. Comparison between coronary artery model (line) and spectra (dots) of carotid artery
samples. A, Nonatherosclerotic. B, Noncalcified atheromatous plaque. C, calcified plaque.
Differences between a spectrum and its model fit are displayed below each comparison (same
scale). Fits of the model to femoral artery were of similar quality.
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teins. Cholesterols also have several steroid ring
vibrations between 1300 and 700 cm–1. The sym-
metric stretching mode of phosphate at 960 cm–1,
which is a constituent of calcium hydroxyapatite,
dominates the spectrum of calcified plaque.19,28-30
Histograms of the total cholesterol content in
each of the designated constituent levels are shown
in Fig. 4, and the mean values and standard devia-
tions of these contents are plotted for each level in
Fig. 5. Histograms of the calcium salt content in
each of the designated constituent levels are shown
in Fig. 6, and the mean values and standard devia-
tions of these contents are plotted for each level in
Fig. 7.
The ROC curve for detecting diseased levels of
cholesterol content by total cholesterol content is
shown in Fig. 8. The area under this curve is 0.84. In
our other Raman-histopathologic study,25 in coro-
nary artery, the decision threshold for differentiating
nonatherosclerotic from atherosclerotic tissues was
found to be 13% total cholesterol, which yields 92%
sensitivity and 53% specificity in this present study.
The ROC curve for detecting diseased levels of min-
eral histochemical level on the basis of calcium salt
content is shown in Fig. 9. The area under this ROC
curve is 0.98. In our other Raman-histopathologic
study,25 the decision threshold for differentiating cal-
cified atherosclerosis from nonatherosclerosis was
found to be 9% calcium salt, which yielded 100% sen-
sitivity and 88% specificity in this study.
Reliable spectra in this study were obtained with
exposure times as short as 5 seconds, although the
Fig. 5. Mean amount of total cholesterol (TC) in each
cholesterol level (CL). The standard deviation of the
TC amount within each CL is indicated by the vertical
error bars.
Fig. 4. Histograms of total cholesterol (TC) percentage
in each cholesterol level (CL). The number of samples
falling in each bin of width 4% is displayed on the vertical
axis. The 167 samples are divided into CL level 0 (n =
131), level 1 (n = 25), level 2 (n = 7), and level 3 (n = 4).
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Fig. 6. Histograms of calcium salt (CS) percentage in
each level of the calcium mineral level (ML). The number
of samples falling in each bin of width 4% is displayed on
the vertical axis. The 167 samples are divided into ML
level 0 (n = 133), level 1 (n = 7), level 2 (n = 6), and level
3 (n = 21).
Fig. 7. Mean amount of calcium salt (CS) in each calci-
um mineral level (ML). The standard deviation of the CS
amount within each ML level is indicated by the vertical
error bars.
Fig. 8. ROC curve for detecting diseased levels of cho-
lesterol on the basis of total cholesterol content. The area
under this curve is 0.84.
firmed the applicability of the Raman model to spec-
tral analysis of peripheral arteries. This finding reflects
the similarity of the anatomy and chemical composi-
tion of all of these arteries, and it establishes the valid-
ity of using the Raman model in future in vitro and in
vivo comparative studies of peripheral arteries.
The correlation between total cholesterol con-
tent and level of disease (Figs. 4 and 5) indicates the
close correspondence between spectroscopically
measured cholesterol content and that determined
from morphologic study. The standard deviation of
total cholesterol content within each level was 10%
or less, and the average content of total cholesterol
increased significantly with each level. Calcium con-
tent also was found to correlate strongly with level
of disease (Figs. 6 and 7), again indicating the cor-
respondence between spectroscopically measured
calcium salt content and that determined at patho-
logic inspection. Unlike the cholesterol comparison,
the standard deviation of calcium content within
each level increased from 10% at level 0 to 24% at
level 3, but the calcium salt content increased signif-
icantly for each level.
The ROC curve provides a simple empirical
description of the performance of a diagnostic test as
the decision threshold is varied. A diagnostic model
with no predictive power produces a straight line
inclined by 45 degrees to the horizontal axis. The
greater the predictive power, the more bowed is the
curve, and the area beneath the curve can serve as a
measure of predictive power. A model with no pre-
dictive power has an area of 0.5; a perfect diagnosis
has an area of 1. The calcium mineral ROC curve in
this study had an area of 0.98, which is nearly per-
fect. The area under the cholesterol ROC curve was
0.84, which indicates that total cholesterol level is a
strong, yet less accurate, diagnostic aid for designat-
ing disease levels. One constructs a ROC curve by
assuming histologic evaluations to be 100% correct,
which is certainly unlikely without use of frozen sec-
tions and lipid stains.
Raman spectroscopy and histologic evaluation are
by nature very different methods of assessing histo-
logic composition, and the two methods should not
be expected to provide identical information. For
example, the two techniques are used to examine dif-
ferent amounts of tissue. Near-infrared light scatters
strongly in human tissue, so near-infrared Raman
spectroscopy can be used to detect material to a
depth of about 1.5 mm and about 1 mm laterally dis-
placed from the 100 m m irradiated spot of arterial tis-
sue.19 Raman analysis of an arterial sample thus
includes contributions from the molecules through-
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signal-to-noise ratio decreased according to the
square root of the integration time. Prolonged laser
exposure of up to 22 minutes did not appreciably
affect or alter the quality of the spectra. No thermal or
other tissue injury was detected with light microscop-
ic examination of normal, fibrotic, or calcified carotid
endarterectomy specimens. No significant variations
of the Raman spectra were observed. Reduction of
fluorescence background was seen with longer expo-
sure times. This may indicate the presence of minor
bleaching of ceroids, the lipopigments.31
DISCUSSION
The results show that chemical contents deter-
mined by Raman spectra correlate strongly with
those obtained with light microscopic examination.
Raman spectroscopy of peripheral artery indicates
not only the presence of disease but also the degree
of alteration of the main constituents of atheroscle-
rotic occlusive disease in an irradiated volume of
arterial wall. Raman spectroscopy has great potential
for pinpoint analysis of the histochemical features of
arterial wall.
The Raman spectral model, developed with coro-
nary artery samples, produced excellent fits to all 167
carotid and femoral artery spectra in this study (Fig.
3). These fits were similar in quality to those obtained
in the earlier application of the model to coronary
artery spectra.24 The high quality of these fits con-
Fig. 9. ROC curve for detecting diseased calcium miner-
al levels on the basis of calcium salt content. The area
under this curve is 0.98.
out this roughly 4 mm3 examined volume, if a 1 mm
radius hemisphere is assumed. In contrast, a patholo-
gist examines specific microstructures in thin cross
sections of the arterial wall. These microstructures
may be rich in specific chemicals, such as free choles-
terol, cholesterol esters, and calcium salts, which
allows detection with Raman spectroscopy. However,
the volumes of tissue sampled differ considerably.
Because Raman spectroscopy is used to examine
a very large microscopic volume in a single measure-
ment, its use may not be feasible for detection of
small levels of microstructures that contribute a total
of less than a few percentage points to the weight of
the examined volume. A pathologist can detect these
structures even if they are focal and small in a given
cross section, which is one possible reason why the
diagnosis of the diseased level does not exhibit per-
fect sensitivity. On the other hand, a pathologist
would need to examine hundreds of 5 m m thick
cross sections to detect all relevant microstructures
in the same volume of tissue examined in one Raman
spectroscopic measurement. In this study, the
pathologist examined only five adjacent sections sep-
arated by about 50 to 100 m m taken from the cen-
ter of the ink mark corresponding to the location at
which spectra were taken.
Histologic information determined at pathologic
examination is limited by the fact that tissue prepara-
tion alters certain components. Decalcification of the
tissue was necessary for preparation of microscopic
sections, but it limited our ability to quantify the cal-
cium mineral deposits, which may account for the
large spread in calcium salt content within levels
determined at histologic examination. Similarly, his-
tologic assessment of foam cells and cholesterol crys-
tals as a measure of lipid content is very different
from the molecule-based spectral response on which
Raman analysis is based. In addition, microscopic
sections were cut after the tissue was processed in
lipolytic solvent and stained with hematoxylin and
eosin rather than a lipid stain. In future studies,
frozen-section specimens with special stains may be
analyzed morphometrically to improve the lipid com-
parisons.
Some inaccuracies in this study may be attributed
to errors in marking the exact tissue location that was
illuminated. The magnitude of the hydroxyapatite
feature (960 cm–1) in an arterial spectrum can
decrease by a factor of three as the examined location
is translated ~1 mm away from a subsurface calcium
deposit.19 As an additional complication, the magni-
tude of a spectral signature in an arterial spectrum
also decreases with the depth of the compound
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below the surface of the arterial wall. The Raman
chemical concentrations measured in this study rep-
resented an average over depth and lateral position.
Microcalcifications and small amounts of calcium
typically are present near the intimal medial interface.
Despite these possible sources of error and dif-
ferences in method, the results of the study are very
positive. The coronary artery model fit the spectra of
carotid and peripheral arteries well, the chemical
amounts calculated by the model correlated strong-
ly with histologic findings at pathologic inspection,
and the disease classification thresholds closely
agreed. These results provide a firm basis for use of
the Raman spectral model to extract histochemical
information from spectra of these arteries and sug-
gest that the coronary artery disease classification
scheme can be used to diagnose atherosclerosis in
peripheral arteries, although that was not a goal of
this study. A separate study is necessary to fully assess
the diagnostic capabilities of the Raman model in
peripheral arteries.
A method of evaluating lesion chemical composi-
tion in situ would be a valuable tool. Raman spec-
troscopy may provide such a method, which may help
identify rupture-prone plaques and allow aggressive
and directed intervention. Accurate knowledge of the
chemical composition of a lesion may also prove use-
ful in selecting a particular treatment modality. This
preliminary study confirmed the feasibility of such an
approach.
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